Invention Grant
- Patent Title: Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
-
Application No.: US14769795Application Date: 2014-03-14
-
Publication No.: US11827693B2Publication Date: 2023-11-28
- Inventor: Michael Wittekind , Adam Vigil
- Applicant: CONTRAFECT CORPORATION
- Applicant Address: US NY Yonkers
- Assignee: CONTRAFECT CORPORATION
- Current Assignee: CONTRAFECT CORPORATION
- Current Assignee Address: US NY Yonkers
- Agency: MH2 TECHNOLOGY LAW GROUP, LLP
- International Application: PCT/US2014/027939 2014.03.14
- International Announcement: WO2014/152841A 2014.09.25
- Date entered country: 2015-08-21
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61K9/00 ; A61K39/42 ; A61K45/06 ; A61K39/00

Abstract:
The present invention provides methods for treatment or prophylaxis of viruses, particularly influenza virus, by administration of agents, particularly neutralizing antibodies or active fragments thereof, directly to the respiratory tract, including by intranasal or inhalation administration. The invention provides compositions suitable for intranasal or inhalation treatment and administration. The invention includes methods for treatment or prophylaxis combining intranasal or inhalation administration with intraperitoneal or intravenous administration of antibodies.
Public/Granted literature
Information query